• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity.

作者信息

Lim S G, Sawyerr A M, Hudson M, Sercombe J, Pounder R E

机构信息

University Department of Medicine, Royal Free Hospital School of Medicine, London, UK.

出版信息

Aliment Pharmacol Ther. 1993 Jun;7(3):317-21. doi: 10.1111/j.1365-2036.1993.tb00103.x.

DOI:10.1111/j.1365-2036.1993.tb00103.x
PMID:8117350
Abstract

The study investigated the oral absorption of two antifungal agents, fluconazole and itraconazole, under conditions of low intragastric acidity. Twelve healthy male volunteers received each of 4 dosing regimens: 200 mg itraconazole alone, 200 mg itraconazole and famotidine, 100 mg fluconazole alone, and 100 mg fluconazole and famotidine. Two oral doses of 40 mg famotidine were used to induce hypochlorhydria. Serum drug concentrations were measured (by high pressure liquid chromatography) for 48 h after a single dose of each anti-fungal agent. When dosed with famotidine, there was a significant 52.9% decrease of the peak intraconazole concentration (P < 0.011), and a significant 51.1% decrease of the 48-h integrated serum intraconazole concentration (P = 0.005). Famotidine-induced hypochlorhydria did not affect the absorption of fluconazole.

摘要

相似文献

1
Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity.
Aliment Pharmacol Ther. 1993 Jun;7(3):317-21. doi: 10.1111/j.1365-2036.1993.tb00103.x.
2
Pharmacokinetics of oral antifungals and their clinical implications.口服抗真菌药物的药代动力学及其临床意义。
Br J Clin Pract Suppl. 1990 Sep;71:50-6.
3
Plasma concentration of itraconazole in patients receiving chemotherapy for hematological malignancies: the effect of famotidine on the absorption of itraconazole.接受血液系统恶性肿瘤化疗患者的伊曲康唑血浆浓度:法莫替丁对伊曲康唑吸收的影响。
Hematol Oncol. 1998 Mar;16(1):33-7. doi: 10.1002/(sici)1099-1069(1998030)16:1<33::aid-hon620>3.0.co;2-9.
4
The triazole antifungal agents: a review of itraconazole and fluconazole.三唑类抗真菌药物:伊曲康唑和氟康唑综述
Pharmacotherapy. 1990;10(2):146-53.
5
Pharmacokinetic optimisation of oral antifungal therapy.口服抗真菌治疗的药代动力学优化
Clin Pharmacokinet. 1993 Oct;25(4):329-41. doi: 10.2165/00003088-199325040-00006.
6
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.食物和剂量对健康受试者中伊曲康唑口服全身可用性的影响。
Eur J Clin Pharmacol. 1989;36(4):423-6. doi: 10.1007/BF00558308.
7
The pharmacokinetics of oral itraconazole in AIDS patients.艾滋病患者口服伊曲康唑的药代动力学。
J Pharm Pharmacol. 1992 Jul;44(7):618-9. doi: 10.1111/j.2042-7158.1992.tb05478.x.
8
Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers.伊曲康唑胶囊在健康男性志愿者中的食物相互作用及稳态药代动力学
Antimicrob Agents Chemother. 1993 Apr;37(4):778-84. doi: 10.1128/AAC.37.4.778.
9
The clinical pharmacokinetics of itraconazole: an overview.伊曲康唑的临床药代动力学:综述
Mycoses. 1989;32 Suppl 1:67-87. doi: 10.1111/j.1439-0507.1989.tb02296.x.
10
Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole.
Eur J Clin Pharmacol. 1994;46(2):147-50. doi: 10.1007/BF00199879.

引用本文的文献

1
Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazole.基于生理的药代动力学模型预测胃 pH 值介导的药物暴露:以伊曲康唑为例的案例研究。
CPT Pharmacometrics Syst Pharmacol. 2023 Jun;12(6):865-877. doi: 10.1002/psp4.12959. Epub 2023 Mar 26.
2
The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles.三唑类药物的药代动力学和药效学相互作用概述
Pharmaceutics. 2021 Nov 19;13(11):1961. doi: 10.3390/pharmaceutics13111961.
3
Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients.
儿科患者全身用抗真菌药物的给药途径和剂量。
Paediatr Drugs. 2020 Apr;22(2):165-188. doi: 10.1007/s40272-020-00379-2.
4
Paradoxical worsening of Emergomyces africanus infection in an HIV-infected male on itraconazole and antiretroviral therapy.一名接受伊曲康唑和抗逆转录病毒治疗的HIV感染男性患者出现非洲埃默菌感染的矛盾性恶化。
PLoS Negl Trop Dis. 2018 Mar 8;12(3):e0006173. doi: 10.1371/journal.pntd.0006173. eCollection 2018 Mar.
5
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.抗真菌药物的药代动力学:优化患者治疗的实际意义。
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
6
Inhibition of antifungal therapy by gastric acid suppressants.
Intensive Care Med. 2015 Mar;41(3):565-6. doi: 10.1007/s00134-015-3673-9. Epub 2015 Feb 21.
7
Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.奈妥匹肽,一种胃泌素受体拮抗剂,在一项针对慢性萎缩性胃炎患者的非随机试验中,可使肿瘤标志物正常化,并使 1 型胃神经内分泌肿瘤消退。
PLoS One. 2013 Oct 1;8(10):e76462. doi: 10.1371/journal.pone.0076462. eCollection 2013.
8
Soluble itraconazole in tablet form using disordered drug delivery approach: critical scale-up considerations and bio-equivalence studies.采用无序药物传递方法的片剂形式的可溶性伊曲康唑:关键放大考虑因素和生物等效性研究。
AAPS PharmSciTech. 2013 Mar;14(1):360-74. doi: 10.1208/s12249-012-9918-9. Epub 2013 Jan 19.
9
Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.利用胃特异性血浆生物标志物诊断和筛查萎缩性胃炎的原理
Scand J Gastroenterol. 2012 Feb;47(2):136-47. doi: 10.3109/00365521.2011.645501.
10
Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.pH 值和伴随用药对泊沙康唑胃肠道吸收的影响:管腔内和血浆药物浓度监测。
Clin Pharmacokinet. 2011 Nov 1;50(11):725-34. doi: 10.2165/11592630-000000000-00000.